University of Tasmania
Browse

File(s) not publicly available

Increased chylomicron triglyceride hydrolysis by connective tissue flow in perfused rat hindlimb: Implications for lipid storage

journal contribution
posted on 2023-05-16, 12:12 authored by Clerk, LH, Smith, ME, Stephen RattiganStephen Rattigan, Michael ClarkMichael Clark
Skeletal muscle has two circulatory routes, nutritive (in contact with muscle) and non-nutritive (part of which is located in the connective tissue), and the balance of flow between the two is controlled by neural input and circulating vasomodulators. The purpose of this study was to assess muscle triglyceride hydrolysis given that the two circuits may have a differing vascular distribution of hydrolytic activity. The isolated rat hindlimb was perfused with 6% Ficoll® and a radiolabeled chylomicron-lipid emulsion containing apolipoprotein C-II. Serotonin (0.5-1 μM), a model vasoconstrictor previously shown to preferentially increase connective tissue flow, inhibited hindlimb oxygen uptake (from 16.7 ± 0.6 to 10.2 ± 1.0, mean ± SE, n = 7 (P <0.001)) and stimulated [14C]-labeled fatty acid uptake into muscles (from 184 ± 28 to 602 ± 132, mean ± SE, n = 7 (P = 0.009)). These effects were reversed by the vasodilator carbamyl choline. Vasopressin resulted in increased oxygen consumption but no change in triglyceride hydrolysis. Cholesteryl oleate uptake (an indicator of endocytosis of the chylomicron or remnant particle) was unaltered by serotonin. It is concluded that chylomicron triglyceride hydrolysis is enhanced by vasoconstrictors that increase connective tissue flow in the perfused rat hindlimb. Increased hydrolysis appears to be primarily due to increased access of triglyceride to hydrolytic enzymes, presumably lipoprotein lipase associated with the fat cells commonly observed interlaced amongst bundles of muscle fibers.

History

Publication title

Journal of Lipid research

Volume

41

Pagination

329-335

ISSN

0022-2275

Department/School

Tasmanian School of Medicine

Publisher

Lipid Research, Inc.

Place of publication

Bethesda, USA

Repository Status

  • Restricted

Socio-economic Objectives

Clinical health not elsewhere classified

Usage metrics

    University Of Tasmania

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC